Recent studies have indicated that the presence of reactive oxygen species (ROS) such as •OH and •O2− plays a pivotal role in the degradation pathways of pharmaceuticals, facilitating the breakdown of complex molecules into simpler, more biodegradable intermediates [Author, Year].